EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.10.1 | 1-acylglycerophosphocholine o-acyltransferase deficiency |
30705887 |
Macrophage Lysophosphatidylcholine Acyltransferase 3 Deficiency-Mediated Inflammation Is Not Sufficient to Induce Atherosclerosis in a Mouse Model. |
causal interaction
ongoing research
unassigned |
1
3
0 |
| 2.7.10.1 | 22q11 Deletion Syndrome |
34152937 |
The blood-brain and gut-vascular barriers: from the perspective of claudins. |
ongoing research
unassigned |
4
0 |
| 2.7.10.1 | Aberrant Crypt Foci |
9394711 |
Fatty acids and colon cancer in experimental models. |
causal interaction
ongoing research
unassigned |
2
1
0 |
| 2.7.10.1 | Aberrant Crypt Foci |
11914921 |
Tissue localization of TGFalpha and apoptosis are inversely related in colorectal tumors. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
4 |
| 2.7.10.1 | Aberrant Crypt Foci |
16214919 |
Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
3
3
0 |
| 2.7.10.1 | Aberrant Crypt Foci |
16740703 |
Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci. |
causal interaction
unassigned |
4
0 |
| 2.7.10.1 | Aberrant Crypt Foci |
17651787 |
The insulin-like growth factor type 1 receptor and colorectal neoplasia: insights into invasion. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
4
0 |
| 2.7.10.1 | Aberrant Crypt Foci |
18413814 |
Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model. |
causal interaction
unassigned |
3
0 |
| 2.7.10.1 | Aberrant Crypt Foci |
25604134 |
A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
4 |
| 2.7.10.1 | Aberrant Crypt Foci |
25803810 |
Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
1
1
0 |
